ABIGAIL LAVY: Open Payments
NPI 1831417161 · BASALT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 6 payments from 5 companies in 2025. Trend: 2023 $45 · 2024 $0 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Medtronic, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: NA, PREVNAR 20, GEMTESA, MYFEMBREE, LEQVIO, MOUNJARO.
Industry payments across CO — which companies pay providers there.
